Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nal-Glu

Home DrugsNal-Glu

Nal-Glu

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Prevention of diabetes by administration of GnRH antagonists
US 2002103131 A1Applicant: JACOBSON JILL DPriority: 2001
CN
US
4 publications
Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy
US 11992537 B2Applicant: PROVINCIAL HEALTH SERVICES AUTHORITYPriority: 2018
CN
US
3 publications
177Lu-DOTA-HYNIC-iPSMA as a therapeutic radiopharmaceutical targeting prostate-specific membrane antigen
US 12128114 B2Applicant: INSTITUTO NAC DE INVESTIGACIONES NUCLEARESPriority: 2018
CN
US
2 publications
Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament
EP 1674082 A1Applicant: ZENTARIS GMBHPriority: 2004
EP
Polypeptide bombesin antagonists
EP 2198878 A1Applicant: UNIV MIAMIPriority: 2008
EP
Novel radiolabelled CXCR4 targeting compounds for diagnosis and therapy
CN 114364690 AApplicant: PROVINCIAL HEALTH SERVICE MECHPriority: 2019
CN
Technetium-labeled specific membrane antigen developer kit as well as preparation method and application thereof
CN 114569744 AApplicant: ANHUI HUANJINTANG PHARMACEUTICAL CO LTDPriority: 2022
CN
DOTA-HYNIC-iPSMA AS A THERAPEUTIC RADIOPHARMACEUTICAL TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN
US 20250009911 A1Applicant: INSTITUTO NAC DE INVESTIGACIONES NUCLEARESPriority: 2024
US